Vancomycin plus rifampicin for methicillin-resistant Staphylococcus aureus pneumonia benefits only those who have no development of rifampicin resistance during treatment
2010 ◽
Vol 38
(8)
◽
pp. 1754-1755
◽
2019 ◽
Vol 21
(1)
◽
pp. 33-39
◽
2017 ◽
Vol 8
(2)
◽
pp. 77
◽
2010 ◽
Vol 38
(7)
◽
pp. 1536-1541
◽
2018 ◽
Vol 119
(6)
◽
pp. 4808-4814
◽
2019 ◽
Vol 358
(4)
◽
pp. 289-293
◽